• Skip to main content
  • Skip to after header navigation
  • Skip to site footer
ERN: Emerging Researchers National Conference in STEM

ERN: Emerging Researchers National Conference in STEM

  • About
    • About AAAS
    • About the NSF
    • About the Conference
    • Partners/Supporters
    • Project Team
  • Conference
  • Abstracts
    • Undergraduate Abstract Locator
    • Graduate Abstract Locator
    • Abstract Submission Process
    • Presentation Schedules
    • Abstract Submission Guidelines
    • Presentation Guidelines
  • Travel Awards
  • Resources
    • Award Winners
    • Code of Conduct-AAAS Meetings
    • Code of Conduct-ERN Conference
    • Conference Agenda
    • Conference Materials
    • Conference Program Books
    • ERN Photo Galleries
    • Events | Opportunities
    • Exhibitor Info
    • HBCU-UP/CREST PI/PD Meeting
    • In the News
    • NSF Harassment Policy
    • Plenary Session Videos
    • Professional Development
    • Science Careers Handbook
    • Additional Resources
    • Archives
  • Engage
    • Webinars
    • ERN 10-Year Anniversary Videos
    • Plenary Session Videos
  • Contact Us
  • Login

Resveratrol-loaded Nanodiamonds (RDNDs): A Candidate for Cancer Therapy

Undergraduate #34
Discipline: Biological Sciences
Subcategory: Cancer Research

Trentyn Shaw - Alabama State University
Co-Author(s): Sanjay Kumar, James Stokes III, Brittany Buck-Hollins, Manoj Mishra



Despite the many chemotherapeutic advancements being made in the 21st century, drug toxicity and drug effectiveness is still a concerning problem. The purpose of this study was to find a drug that would produce little to no toxicity and conjugate it to a drug-carrying vehicle to be tested against healthy and cancerous cell lines with the hypothesis that it would kill the cancerous cells but not harm the healthy cells. The drug of study in this experiment was resveratrol (RES) which is a natural polyphenolic compound found in several plants and has shown to have many beneficial characteristics such as being an antioxidant. It has also been noted that resveratrol has shown anti-cancer and anti-proliferation characteristics as well which makes it a candidate for anticancer therapeutic drugs. In this study, resveratrol was conjugated to nanodiamonds (DND), a carbon containing nano compound derived from high destructive collisions such as explosions that contains cancer-therapeutic and imaging properties, and tested against Transgenic Adenocarcinoma of Mouse Prostate (TRAMP C1, C2, and C3) cell lines. TRAMP C1 and C2 is tumorigenic (forms tumor) while TRAMP C3 non-tumorigenic (does not form tumor) . Briefly, TRAMP cells were cultured and treated with different concentrations of DND, RES, and RDNDs (resveratrol loaded nanodiamonds) in 96-well plates (triplicates), incubated at different time points and analyzed for for cell viability/toxicity and apoptotic pathways. The data collected revealed that RDNDs did indeed modulated 1) the proliferation of the TRAMP C1, C2 and C3 cells, 2) brought significant changes in the mitochondrial membrane potential, and 3) modulated the apoptotic pathways. Therefore, this study shows that the effects of resveratrol can be enhanced when conjugated to nanodiamonds and could be a possible cancer therapeutic drug

delivery system.

Funder Acknowledgement(s): Funding Acknowledgement(s): This work was supported in part by grants from National Institutes of Health P20CA192976 and the National Science Foundation (DUE-1154214)

Faculty Advisor: Manoj Mishra, mmishra@alasu.edu

Role: I was involved in the resveratrol nanodiamond synthesis and testing them against the various cell lines.

Sidebar

Abstract Locators

  • Undergraduate Abstract Locator
  • Graduate Abstract Locator

This material is based upon work supported by the National Science Foundation (NSF) under Grant No. DUE-1930047. Any opinions, findings, interpretations, conclusions or recommendations expressed in this material are those of its authors and do not represent the views of the AAAS Board of Directors, the Council of AAAS, AAAS’ membership or the National Science Foundation.

AAAS

1200 New York Ave, NW
Washington,DC 20005
202-326-6400
Contact Us
About Us

  • LinkedIn
  • Facebook
  • Instagram
  • Twitter
  • YouTube

The World’s Largest General Scientific Society

Useful Links

  • Membership
  • Careers at AAAS
  • Privacy Policy
  • Terms of Use

Focus Areas

  • Science Education
  • Science Diplomacy
  • Public Engagement
  • Careers in STEM

Focus Areas

  • Shaping Science Policy
  • Advocacy for Evidence
  • R&D Budget Analysis
  • Human Rights, Ethics & Law

© 2023 American Association for the Advancement of Science